S.-T. Huang et al. / Dyes and Pigments 86 (2010) 6e14
9
104.5, 97.7, 51.8, 51.4, 29.3, 20.2, 13.8. HRMS-ESI (m/z): [M þ 1] For
d
¼ 8.06 (d, J ¼ 9.2 Hz, 1H), 7.99 (d, J ¼ 7.6 Hz, 1H), 7.62 (t, J ¼ 7.6 Hz,
C33H33N5O3, 547.2583 calcd; 548.2705 found.
1H), 7.56 (t, J ¼ 7.6 Hz, 1H), 7.39 (d, J ¼ 9.2 Hz, 1H), 7.18 (s, 1H), 3.76
(q, J ¼ 7.0 Hz, 4H), 1.33 (t, J ¼ 7.0 Hz, 6H). HRMS-ESI (m/z): [M þ 1]
For C24H18N6O, 406.1542 calcd; 407.1598 found.
2.2.9. N,N-Diethyl-7-[(4-bromophenyl)imino]-7H-chromeno
[20, 30: 4, 5] pyrimido [1, 6-a] benzimidazol-3-amine (4i) ꢂ1
Red solid (68% yield) m.p. 290e292 ꢁC. FT-IR v/cm ¼ 2971,
2928, 2868, 1637, 1590, 1556, 1526, 1510, 1480, 1421, 1339, 1264,
2.4.2. 3-(Dibutylamino)-7-imino-7H-chromeno [30, 20: 3, 4]
pyrido [1, 2-a] benzimidazole-6, 14-dicarbonitrile (5b)
.
1231, 1185, 1133, 1112, 1097, 1077, 1005 cmꢂ1 1H NMR (500 MHz,
Deep blue solid (77% yield) m.p. > 300 ꢁC. FT-IR v/cmꢂ1 ¼ 3305,
2956, 2928, 2871, 2217, 1666, 1621, 1601, 1547, 1508, 1445, 1425,
1359, 1340, 1306, 1278, 1225, 1186, 1153, 1110, 1074. 1H NMR
CDCl3):
d
¼ 8.75 (d, J ¼ 7.7 Hz, 1H), 8.60 (s, 1H), 7.83 (d, J ¼ 7.7 Hz,
1H), 7.49 (d, J ¼ 8.5 Hz, 2H), 7.50e7.40 (m, 3H), 7.21 (d, J ¼ 8.5 Hz,
2H), 6.72 (dd, J ¼ 9.0, 2.3 Hz, 1H), 6.66 (d, J ¼ 2.3 Hz, 1H), 3.48 (q,
J ¼ 7.1 Hz, 4H), 1.26 (t, J ¼ 7.1 Hz, 6H). 13C NMR (500 MHz, CDCl3):
(500 MHz, CDCl3):
d
¼ 8.69 (s, 2H), 7.92 (dd, J ¼ 6.9, 2.3 Hz,1 H), 7.76
(d, J ¼ 9.2 Hz, 1H), 7.46e7.43 (m, 2H), 6.74 (dd, J ¼ 9.2, 2.3 Hz, H),
6.58 (d, J ¼ 2.3 Hz, 1H), 3.43 (t, J ¼ 7.9 Hz, 4H), 1.66 (t, J ¼ 7.1, 4H),
1.47e1.40 (m, 4H), 1.03e1.00 (t, J ¼ 7.4 Hz, 6H). HRMS-ESI (m/z):
[M þ 1] For C28H26N6O, 462.2186 calcd; 463.2253 found.
d
¼ 161.6, 156.1, 153.0, 147.0, 144.2, 136.0, 131.6, 131.5, 130.8, 125.2,
124.8, 123.9, 118.8, 116.8, 116.4, 110.9, 110.1, 104.8, 97.6, 45.4, 29.7,
18.3, 12.4. HRMS-ESI (m/z): [M þ 1] For C27H22BrN5O, 511.1008,
513.0987 calcd; 512.1101, 514.1080 found.
2.5. General procedures for preparation of 6aeb and 7aeb
2.2.10. N,N-Dibutyl-7-[(4-bromophenyl)imino]-7H-chromeno
[20, 30: 4, 5] pyrimido [1, 6-a] benzimidazol-3-amine (4j) ꢂ1
Red solid (68% yield) m.p. 232e234 ꢁC. FT-IR v/cm ¼ 2956,
2930, 2872, 1634, 1591, 1553, 1529, 1509, 1481, 1420, 1341, 1273,
1249, 1219, 1130, 1111, 1068, 1007. 1H NMR (500 MHz, CDCl3):
In a flask fitted with a magnetic stirrer placed 2.6 mmol of
either 3aeb or 5aeb, and 26 ml of dry pyridine and heated up to
120 ꢁC under an argon atmosphere. At 120 ꢁC, 4-chlorosulfonyl-
benzoic acid (10 mmol) was added and the ensuing mixture was
stirred overnight. The pyridine in the mixture was removed under
reduced pressure to yield the crude oily product which was added
10 ml of 2 M aq HCl to give blue precipitate. The resulting
crude precipitate was collected, washed with water and methanol
and purified by flash column chromatography (1:25/MeOH:
CH2Cl2).
d
¼ 8.75 (d, J ¼ 7.8 Hz, 1H), 8.61 (s, 1H), 7.83 (d, J ¼ 7.8 Hz, 1H), 7.49
(d, J ¼ 8.5 Hz, 2H), 7.46e7.39 (m, 3H), 7.21 (d, J ¼ 8.5 Hz, 2H), 6.68
(dd, J ¼ 8.9, 2.3 Hz,1H), 6.61 (d, J ¼ 2.3 Hz, H), 3.37 (t, J ¼ 7.8 Hz, 4H),
1.65e1.59 (t, J ¼ 7.2 Hz, 4H), 1.43e1.36 (m, 4H), 0.99 (t, J ¼ 7.4 Hz,
6H). 13C NMR (500 MHz, CDCl3):
d
¼ 161.6, 156.0, 153.4, 147.0, 145.7,
144.2,136.2,131.6,131.4,130.8,125.2,124.8,123.9,118.7,116.8,116.4,
111.1, 110.1, 104.4, 97.7, 51.4, 29.7, 29.3, 20.2, 13.9. HRMS-ESI (m/z):
[M þ 1] For C31H30BrN5O, 567.1634, 569.1613 calcd; 568.1765,
570.1701 found.
2.5.1. 4-({6-Cyano-3-(diethylamino)-7H-chromeno[30, 20: 3, 4]
pyrido [1, 2-a] benzimidazol-7-ylidene} amino) sulfonyl
benzoic acid (6a)
2.3. Procedures for preparing 3-(dibutylamino)-7-imino-7H-
chromeo[30, 20: 3, 4] pyrido [1, 2-a] benzimidazole-
6-carbonitrile (3b)
Deep blue solid (43% yield) m.p. > 300 ꢁC. FT-IR v/cmꢂ1 ¼ 3456,
1614, 1551, 1502, 1465, 1346, 1295, 1182, 1130, 1038, 1010. 1H NMR
(500 MHz, DMSO-d6):
d
¼ 9.04 (s, 1H), 8.53 (d, J ¼ 8.5 Hz, 1H), 8.0
(d, J ¼ 7.0 Hz, 2H), 7.91 (d, J ¼ 9.5 Hz 1H), 7.84 (d, J ¼ 7.6 Hz, 1H), 7.70
(d, J ¼ 7.0 Hz, 2H), 7.50 (t, J ¼ 7.6 Hz, 1H), 7.53 (t, J ¼ 7.6 Hz, 1H), 7.11
(d, J ¼ 9.5 Hz, 2H), 6.87 (s, 1H), 3.61 (q, J ¼ 7.0 Hz, 4H), 1.19 (t,
J ¼ 7.0 Hz, 6H). HRMS-ESI (m/z): [M ꢂ 1] For C30H23N5O5S, 565.1420
calcd; 564.1341 found.
To a solution of 1b (1 mmol) in 3 ml dry 2-methoxyethanol
was added malononitrile (1 mmol), and the solution was stirred
80 ꢁC for 4 h. The mixture was cooled to room temperature and
the red coloured precipitate was filtered and purified by recrys-
tallisation with DMF toꢂ1give 3b as red solid (68% yield). M.p.
296e299 ꢁC. FT-IR v/cm ¼ 3333, 3190, 2957, 2208, 1356, 1276,
1222, 1169, 1124. 1H NMR (500 MHz, DMSO-d6):
d
¼ 8.76 (d,
2.5.2. 4-({6-Cyano-3-(dibutylamino)-7H-chromeno[30, 20: 3, 4]
pyrido [1, 2-a] benzimidazol-7-ylidene} amino) sulfonyl)
benzoic acid (6b)
J ¼ 7.6 Hz, 1H), 8.05 (s, 1H), 8,41 (br, 1H, NH), 7.80 (d, J ¼ 7.6 Hz,
1H,), 7.42 (m, 3H), 6.68 (dd, J ¼ 9.0, 2.1 Hz, 1H), 6.63 (s, 1H), 3.41 (t,
J ¼ 7.9 Hz 4H,), 1.65 (m, 4H), 1.46e1.39 (m, 4H), 1.25e0.98 (m, 6H).
HRMS-ESI (m/z): [M] For C27H27N5O, 437.2216 calcd; 437.2230
found.
Deep blue solid (51% yield) m.p. > 300 ꢁC. FT-IR v/cmꢂ1 ¼ 3452,
2955, 2214, 1640, 1549, 1505, 1471, 1338, 1287, 1222, 1172, 1128,
1037, 1009. 1H NMR (500 MHz, DMSO-d6):
d
¼ 9.04 (s, 1H), 8.52 (d,
J ¼ 8.3 Hz, 1H), 8.01 (d, J ¼ 8.3 Hz, 2H), 7.90 (d, J ¼ 9.2 Hz, 1H), 7.83
(d, J ¼ 8.2 Hz,1H), 7.71 (d, J ¼ 8.3 Hz, 2H), 7.48 (t, J ¼ 8.2 Hz,1H), 7.42
(t, J ¼ 8.3 Hz, 1H), 7.09 (d, J ¼ 9.2 Hz, 1H), 6.84 (s, 1H) 3.53
(t, J ¼ 7.4 Hz, 4H), 1.56e1.55 (m, 4H), 1.35 (m, 4H), 0.92 (t, J ¼ 7.3 Hz,
6H). HRMS-ESI (m/z): [M ꢂ 1] For C34H31N5O5S, 621.2046 calcd;
620.1971 found.
2.4. General preparation of 5a and 5b
To a solution of 5 (20 mmol) in 50 ml of DMF was added
potassium cyanide (40 mmol in 6 ml of water). The solution was
stirred at 40 ꢁC for 1 h, cooled to room temperature and filtered.
After filtration, 20 mmol of elemental bromine was added dropwise
to the filtrate at 0 ꢁC and the ensuing mixture was stirred for an
additional 60 min at this temperature. The resulting precipitate was
collected, washed with water and methanol and purified by double
recrystallisation from DMF.
2.5.3. 4-({6, 14-Dicyano-3-(diethylamino)-7H-chromeno[30, 20:
3, 4] pyrido [1, 2-a] benzimidazol-7-ylidene} amino) sulfonyl
benzoic acid (7a)
Deep blue solid (42% yield) m.p. > 300 ꢁC. FT-IR v/cmꢂ1 ¼ 3446,
2924, 1607, 1547, 1445, 1335, 1232, 1186, 1109, 1035, 1007. 1H NMR
2.4.1. 3-(Diethylamino)-7-imino-7H-chromeno [30, 20: 3, 4]
pyrido [1, 2-a] benzimidazole-6, 14-dicarbonitrile (5a)
(500 MHz, DMSO-d6):
d
¼ 8.51 (d, J ¼ 8.0 Hz, 1H), 7.99 (d, J ¼ 8.0 Hz,
1H), 7.93 (d, J ¼ 7.6 Hz, 1H), 7.79 (d, J ¼ 9.2 Hz, 2H), 7.72 (d,
J ¼ 8.0 Hz, 2H), 7.54e7.49 (m, 2H), 7.22 (d, J ¼ 9.2 Hz, 1H), 6.92 (s,
1H), 3.64 (q, J ¼ 7.1 Hz, 4H), 1.20 (t, J ¼ 7.1 Hz, 6H). HRMS-ESI (m/z):
[M ꢂ 1] For C31H22N6O5S, 590.1372 calcd; 589.1298 found.
Deep blue solid (70% yield) m.p. > 300 ꢁC. FT-IR v/cmꢂ1 ¼ 3293,
2978, 2213, 1643, 1599, 1533, 1504, 1475, 1434, 1334, 1310, 1289,
1260,1185,1151,1111,1079,1015. 1H NMR (500 MHz, acetic acid-d4):